Bionoid Pharma Inc. (BINP)
OTCMKTS
· Delayed Price · Currency is USD
0.1100
+0.0023 (2.14%)
May 27, 2025, 9:30 AM EDT
Bionoid Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | 2004 - 2008 |
|---|---|---|---|---|---|---|
Period Ending | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | 2004 - 2008 |
| Net Income | -1.62 | 0.11 | -3.96 | -3.91 | -3.41 | Upgrade
|
| Depreciation & Amortization | 0 | 0 | 0.03 | 0.03 | 0.04 | Upgrade
|
| Other Amortization | - | - | - | 0 | 0.41 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0 | 0 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.35 | - | 0.25 | - | - | Upgrade
|
| Stock-Based Compensation | - | 0.2 | 2.76 | 1.88 | 1.82 | Upgrade
|
| Other Operating Activities | -0.19 | -0.53 | -1.13 | -0.01 | 0.1 | Upgrade
|
| Change in Accounts Receivable | -0 | - | - | - | - | Upgrade
|
| Change in Inventory | 0.01 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 0.04 | 0.13 | 1.11 | 0.31 | 0.06 | Upgrade
|
| Change in Other Net Operating Assets | 0.05 | 0 | 0.01 | -0.02 | 0.51 | Upgrade
|
| Operating Cash Flow | -0.36 | -0.09 | -0.92 | -1.72 | -0.48 | Upgrade
|
| Capital Expenditures | - | - | -0 | -0.01 | -0 | Upgrade
|
| Cash Acquisitions | -0.02 | - | - | - | - | Upgrade
|
| Divestitures | - | - | -0.05 | - | - | Upgrade
|
| Other Investing Activities | - | -0.07 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.02 | -0.07 | -0.05 | -0.01 | -0 | Upgrade
|
| Short-Term Debt Issued | 0.26 | 0.13 | 0 | 0.12 | 0.07 | Upgrade
|
| Total Debt Issued | 0.26 | 0.13 | 0 | 0.12 | 0.07 | Upgrade
|
| Short-Term Debt Repaid | - | -0 | -0.01 | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.04 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -0.04 | -0 | -0.01 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 0.22 | 0.13 | -0.01 | 0.12 | 0.07 | Upgrade
|
| Issuance of Common Stock | 0.11 | 0.13 | - | 2.45 | 0.51 | Upgrade
|
| Other Financing Activities | - | -0.01 | - | - | - | Upgrade
|
| Financing Cash Flow | 0.32 | 0.25 | -0.01 | 2.57 | 0.58 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | 0.02 | Upgrade
|
| Net Cash Flow | -0.06 | 0.08 | -0.98 | 0.84 | 0.11 | Upgrade
|
| Free Cash Flow | -0.36 | -0.09 | -0.92 | -1.73 | -0.49 | Upgrade
|
| Free Cash Flow Margin | -387.63% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -10.20 | -5.38 | -60.05 | -145.33 | - | Upgrade
|
| Cash Interest Paid | 0 | - | 0.01 | 0.02 | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | 0 | Upgrade
|
| Levered Free Cash Flow | -0.44 | -0.96 | -0.4 | -0.23 | 0.7 | Upgrade
|
| Unlevered Free Cash Flow | -0.4 | -0.95 | -0.4 | -0.22 | 0.59 | Upgrade
|
| Change in Net Working Capital | 0.16 | 0.87 | 0.19 | -0.3 | -0.57 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.